Merck’s Vioxx liability could reach $18 billion

Analysts have estimated that Merck's potential liability could reach $18 billion in lawsuits over its withdrawn COX-2 drug Vioxx, according to a report in today's Wall Street Journal.
A federal judge in New Orleans told lawyers yesterday that there could ultimately be up to 100,000 cases filed against Merck and that he could hear a case as early as this fall, the Journal report said.
The first cases are set to be heard in state courts – Texas in July and New Jersey in August – with a case in Alabama currently postponed. 
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.